{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T19:42:17Z","timestamp":1700768537082},"reference-count":16,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T00:00:00Z","timestamp":1134432000000},"content-version":"vor","delay-in-days":6648,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1987,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The kinetic interaction between salicylate and naproxen was investigated in 25 rheumatoid arthritis patients. Kinetic interactions were tested in serum after patients had been on each drug regimen for 1 month. Salicylate decreased serum naproxen concentration from 89.5 mg\/liter to 65.9 mg\/liter (<jats:italic>P<\/jats:italic> &lt; 0.001) and increased serum naproxen clearance by 56%. Naproxen had minimal effect on serum salicylate concentrations.<\/jats:p>","DOI":"10.1002\/art.1780301011","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T21:45:12Z","timestamp":1171489512000},"page":"1157-1161","source":"Crossref","is-referenced-by-count":8,"title":["Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis"],"prefix":"10.1002","volume":"30","author":[{"given":"Daniel E.","family":"Furst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Sarkissian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Blocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Cassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Dromgoole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Robert","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold E.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.152"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02505.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80017-0"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01062103"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160508"},{"key":"e_1_2_1_7_2","first-page":"397","article-title":"Pharmacokinetic and pharmacodynamic implications of long term administration of non\u2010steroidal anti\u2010inflammatory agents","volume":"15","author":"Muller FO","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974154374"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997709108977"},{"key":"e_1_2_1_10_2","first-page":"175","article-title":"1958 revision of diagnostic criteria for rheumatoid arthritis","volume":"9","author":"Ropes MW","year":"1958","journal-title":"Bull Rheum Dis"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)88190-5"},{"key":"e_1_2_1_12_2","first-page":"82","article-title":"Salicylate clearance, the result of protein binding and metabolism","volume":"25","author":"Furst DE","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.20.1457"},{"key":"e_1_2_1_14_2","first-page":"85","volume-title":"Statistical Principles In Experimental Design","author":"Winer BJ","year":"1971"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.103"},{"key":"e_1_2_1_16_2","first-page":"229","article-title":"Optical studies of drug protein complexes. V. The interaction of phenylbutazone, flufenamic acid and dicumarol with acetylsalicylic acid\u2010treated human serum albumin","volume":"7","author":"Chignell CF","year":"1971","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300204"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780301011","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780301011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T19:04:14Z","timestamp":1700766254000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780301011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1987,10]]}},"alternative-id":["10.1002\/art.1780301011"],"URL":"https:\/\/doi.org\/10.1002\/art.1780301011","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,10]]}}}